4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-036463
Chief Scientific Officer acquired 230,645 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taveras Arthur Chief Scientific Officer | 2023-10-31 | Grant or award | +230,645 | 317,018 | D |
Loading xslF345X05/wk-form4_1698958731.xml…